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Thoracoscopic cardiac surgery is presently under intense investigation. This 
study examined the feasibility and efficacy of closed chest cardiopulmonary 
bypass and cardioplegic arrest in comparison with standard open chest 
methods in a dog model. The minimally invasive closed chest group (n = 6) 
underwent percutaneous cardiopulmonary bypass and cardiac venting, as well 
as antegrade cardioplegic arrest hrough use of a specially designed percuta- 
neous endovascular ortic occluder and cardioplegic solution delivery system. 
The control group (n = 6) underwent standard sternotomy and conventional 
open chest cardiopulmonary b pass, aortic crossclamping, and antegrade 
cardioplegia. Ischemic arrest time was 1 hour in each group. Ventricular 
pressures and sonomicrometer segment lengths were recorded before bypass 
and at 30 and 60 minutes after bypass. Left ventricular function did not differ 
significantly between the two groups, as demonstrated bymeasurements of 
elastance and end-diastolic stroke work. Also, the preload recruitable work 
area was 69% and 60% of baseline at 30 and 60 minutes after bypass in the 
minimally invasive group versus 65% and 62% in the conventional control 
group (p = not significant); the stroke work end-diastolic length relationship 
was 78% and 71% of baseline in the minimally invasive group at these intervals 
versus 77% and 74% in the conventional control group (p = not significant). 
Myocardial temperatures were similar throughout bypass in the two groups, 
and ultrastructural examination of prebypass and postbypass biopsy speci- 
mens showed no differences between groups. These results demonstrate hat  
minimally invasive cardiopulmonary b pass with cardioplegic arrest is as 
feasible, safe, and effective as conventional open chest cardiopulmonary 
bypass. Thus current echnology may allow wider clinical application of closed 
chest cardiac surgery. (J THORAC CARDIOVASC SURG 1996;111:556-66) 
R ecent enthusiasm for minimally invasive surgery ~has been fueled by the success of laparoscopic 
and thoracoscopic techniques. These methods have 
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allowed patients to undergo increasingly complex 
procedures without the pain and morbidity associ- 
ated with standard open surgical techniques. The 
benefits of such an approach are obvious. Until re- 
cently, however, minimally invasive cardiac surgery has 
not been feasible, mainly because of limitations in 
percutaneous perfusion technology, limitations in op- 
erative exposure and suturing techniques with the 
closed chest approach, and lack of availability of a 
percutaneous myocardial protection system. 
As early as 1962 Dennis and associates 1 described 
the use of left heart bypass without horacotomy for 
surgical catastrophes that could not be addressed by 
other means. Others subsequently reported success- 
ful application of percutaneous cardiopulmonary 
support systems. 27 These previous methods, how- 
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ever, were developed primarily for use in emergency 
situations and for temporary cardiac support. Like- 
wise, femoral vein-femoral artery cardiopulmonary 
bypass (CPB) has been in use for decades, and 
improved percutaneous perfusion systems recently 
have become available. Nevertheless, until now 
these systems have had limited appeal as a result of 
certain inherent disadvantages. For example, no 
minimally invasive system has yet been able to 
simultaneously provide effective CPB and cardiople- 
gic arrest. In addition, ventricular decompression 
and venting have not been possible during percuta- 
neous perfusion. Moreover, the feasibility of percu- 
taneous cardioplegic arrest and myocardial protec- 
tion has not been well established. If minimally 
invasive closed chest cardiac surgery is to develop, 
these issues need to be resolved. 
The original percutaneous myocardial protection 
system was proposed and developed at Stanford 
University. Our laboratories recently have under- 
taken a series of studies to examine in an animal 
model the feasibility of closed chest cardiac surgical 
techniques. These include newly developed endo- 
vascular myocardial protection systems and thora- 
coscopic dissection and suture methods, applied in 
conjunction with conventional techniques, such as 
diathermy-assisted dissection and percutaneous 
femoral vein-femoral artery bypass. The two pur- 
poses of this study were (1) to determine if percu- 
taneous minimally invasive CPB and cardioplegic 
arrest are feasible with newly available technology 
and (2) to compare the effectiveness of the mini- 
mally invasive approach with that of conventional 
methods. 
Materials and methods 
Study groups. Twelve heartworm-free mongrel dogs 
(25 to 30 kg) were divided into two groups. In the 
minimally invasive group (n = 6) CPB was established 
with an endovascular ortic clamp (Endoclamp device; 
Heartport, Inc., Redwood City, Calif.) used for aortic 
occlusion and endovascular delivery of cardioplegic solu- 
tion and an endovascular pulmonary artery venting cath- 
eter (Heartport) for pulmonary artery venting. In the 
conventional group (n = 6) CPB was established by 
opening the chest and using a standard aortic crossclamp 
with antegrade delivery of cardioplegic solution into the 
aortic root via an aortic root catheter and a standard 
pulmonary artery vent. All animals were given humane 
care in compliance with the "Principles of Laboratory 
Animal Care" formulated by the National Society for 
Medical Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). 
Surgical preparation. In all animals anesthesia was 
initiated with a 4% solution of thiamylal (0.5 mg/kg) and 
maintained with metocurine iodide (0.5 mg/kg) and 
c~-chloralose (100 mg/kg) after endotracheal intubation. 
The animals were supported with a mechanical ventilator 
(Harvard Apparatus Co., Dover, Mass.) and their lungs 
were ventilated with 100% oxygen. All animals were 
monitored throughout the entire procedure with electro- 
cardiography and measurement of carotid arterial pres- 
sure with a micromanometer (Koenigsberg Instruments 
Inc., Pasadena, Calif.), pulmonary artery and central 
venous pressures with a pulmonary artery catheter (Arrow 
International, Inc., Reading, Pa.), and oxygen saturation 
via an external pulse oximeter. Arterial blood gases and 
pH were kept in the normal range by adjusting inspired 
oxygen concentration a d minute ventilation or by admin- 
istering sodium bicarbonate. Electrolyte and hematocrit 
levels were also monitored at appropriate intervals 
throughout the procedure. No transfusions were given to 
either group. 
Surgical technique 
Minimally invasive CPB group. The technique of mini- 
mally invasive CPB was accomplished asshown in Fig. 1. 
A femoral venous catheter (17F cannula, model 58517, 
DLP, Inc., Grand Rapids, Mich.) was placed through a 
cutdown in the left femoral vein and guided by means of 
a fluoroscope (MCA 30, Ratheon, Tokyo, Japan) over a 
guide wire to a position just within the superior vena cava. 
A femoral arterial cannula (14F, model 57414, DLP) was 
placed into the left femoral artery. These catheters were 
connected to the bypass pump (Shiley S-100A Bubble 
Oxygenator, Shiley Inc., Irvine, Calif., and Pemco roller 
pump, model 5745, Pemco Inc., Cleveland, Ohio) in a 
standard fashion. Next, an endovascular pulmonary artery 
venting catheter (Heartport) was inserted into the exter- 
nal jugular vein and guided into position over a flow- 
directed pulmonary artery balloon catheter by means of 
fluoroscopy. The pulmonary artery venting catheter 
served the dual purpose of monitoring pulmonary artery 
pressure while in line with a pressure manometer or 
decompressing the left ventricle during CPB. 
An endovascular ortic clamp (Endoclamp device) was 
positioned under fluoroscopic guidance via the femoral 
artery into the ascending aorta by means of a guide wire 
and dilator. The Endoclamp device is a triple-lumen 
catheter with an inflatable balloon at its distal end. 
Positioning of the balloon was initially confirmed with 
instillation of a small aliquot of dilute radiopaque contrast 
medium (Hypaque sodium; Sanofi Winthrop Pharmaceu- 
ticals, New York, N.Y.) through the central lumen, which 
communicates with the tip of the catheter positioned in 
the aortic root. The balloon, inflated via the second 
lumen, provided an endovascular "crossclamp" by occlud- 
ing the ascending aortic outflow tract (Fig. 2). The balloon 
was positioned so that it rested in the aorta without 
occlusion of the coronary ostia or aortic arch vessels. 
Proper placement of the balloon was confirmed by the 
instillation of approximately 10 ml of 50% radiopaque 
contrast material through the central lumen into the aortic 
root while the balloon was inflated. The position of the 
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Fig. 1. Diagram of the minimally invasive CPB system used in this series of experiments. 
Endoclamp device was also reevaluated before deflation 
of the balloon at the end of crossclamping. Cardioplegic 
solution was delivered through the central lumen, which 
also acted as an aortic root vent. Aortic root pressure was 
monitored through a third separate lumen. The chest 
remained closed throughout the placement of these cath- 
eters. A small subxiphoid incision was made for placement 
of crystals to measure segment length and temperature 
probes, as discussed later in this article. Bicaval control 
was obtained with the use of an umbilical tape and snare. 
The subxiphoid incision was reapproximated after place- 
ment of all monitoring devices and before any measure- 
ments of cardiac function, pressure, or temperature were 
made. 
Conventional CPB group. In the conventional group a 
standard approach was used to implement CPB. The chest 
cavity was surgically opened in the midline with a median 
sternotomy and remained open throughout he entire 
experiment. CPB was achieved after a venous catheter 
(32F, model V 122-32, St6ckert-Shiley, Irvine, Calif.) was 
inserted into the right atrial appendage and secured in 
position. An arterial cannula (16F, USCI, C.R. Bard, Inc., 
Billerica, Mass.) was placed into the left femoral artery, 
and a 16-gauge Angiocath catheter (Deseret Medical, 
Sandy, Utah) was used to vent the pulmonary artery. A 
separate 18-gauge Angiocath catheter was inserted into 
the ascending aorta and used to deliver cardioplegic 
solution, to vent the aortic root, or to measure aortic root 
pressures. Bicaval control was obtained in the manner 
previously described. 
CPB and delivery of cardioplegic solution. All animals 
underwent otal CPB after systemic delivery of heparin 
(100 U/kg). They were cooled to a temperature of 28 ° C 
and subjected to CPB at flow rates of approximately 100 
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Fig. 2. Roentengram illustrating the proper position of the endovascular aortic clamp (EAC) in the 
ascending aorta with opacification of the balloon at the tip of the catheter. The endovascular pulmonary 
artery venting catheter (EPV) and the venous bypass cannula (VC) are overlying the cardiac silhouette. 
ml/kg per minute. Arterial oxygen tension was maintained 
at greater than 70 mm Hg, and the mean arterial pressure 
during CPB was maintained at greater than 60 mm Hg by 
adjusting CPB flow. Venous return was aided in both 
groups by attachment of the venous return cannula to a 
centrifugal pump (Bio-pump, Medtronic Bio-Medicus, 
Eden Prairie, Minn.). The ascending aorta was occluded 
with a vascular clamp or by inflation of the balloon of the 
Endoclamp device. Multiple doses of cardioplegic solu- 
tion were given antegradely either through the distal end 
of the Endoclamp device or through the aortic root 
catheter. Both groups received Freme's cardioplegic solu- 
tion, s and oxygenated blood cardioplegic solution was 
cooled to 6 ° C in a BCD Plus Heat Exchanger (Shiley). A 
high potassium dose of 20 ml/kg (20 to 24 mEq/L final 
concentration) was given initially to arrest the heart, 
followed by a potassium mixture of 10 ml/kg (8 to 12 
mEq/L final concentration) given at 15-minute intervals. 
All doses were given at a rate of 75 ml/min with blood 
mixed with cardioplegic solution n a ratio of four to one. 
The hematocrit value during CPB remained above 25% in 
all cases. The pulmonary artery and the aortic root were 
vented throughout CPB and drained into the oxygenator 
reservoir. After 1 hour of CPB, the blood temperature was 
warmed to more than 35 ° C and the aorta was unclamped. 
If necessary, the heart was defibrillated. The heart was 
then allowed to rewarm to 37 ° C. Data acquisition was 
continued for 60 minutes after the completion of CPB. 
Measurement of left ventricular segment length and pres- 
sure. Instantaneous myocardial segment dimensions were 
measured with subepicardial pulse-transit ultrasonic di- 
mension transducers (model CY5; Triton Technology, 
Inc., San Diego, Calif.). They were placed in the epicar- 
dium, via a stab incision, 5 cm apart along the left 
ventricle, midway between the base and apex. The piezo- 
electric crystals were then connected to an oscilloscope 
and sonomicrometer (model 100; Triton Technology) for 
calibration and recording of analog output. 
Ventricular pressures were recorded continuously with 
micromanometers (models MPC-500 and SPC-450; Millar 
Instruments, Inc., Houston, Tex.) placed into the apices 
via stab incisions. All micromanometers were calibrated 
over a similar ange and then allowed to equilibrate to 37 ° 
C. The sinus node was crushed with a clamp, and the right 
atrium was electronically paced (Medtronic, Inc., Minne- 
apolis, Minn.) at a constant rate of 150 beats/rain. 
Myocardial contractile data acquisition and analysis. 
Ventricular pressure and myocardial segment dimensions 
were measured just before CPB (pre-CPB), 30 minutes 
after the completion of CPB, and 60 minutes after the 
completion of CPB. Five sets of data were acquired uring 
each measurement. Each set of data acquisition lasted 30 
seconds and was recorded over a range of left ventricular 
end-diastolic volumes produced by transient (10 seconds) 
bicaval occlusions. The method for measuring cardiac 
function was based on algorithms developed by other 
investigators. 9-a3 The indexes of regional eft ventricular 
systolic contractile function calculated were the slope of 
the end-diastolic pressure-length relationship (Mw), the x- 
intercept of the end-diastolic pressure-length relationship 
(Lw), the preload recruitable work area, the stroke work- 
end-diastolic length relationship, and maximal regional 
elastance (Emax). 
Ventricular temperature measurements. Myocardial ther- 
mistors were placed into the right and left ventricular f ee 
walls and attached to a digital thermometer (Shiley). 
Temperature readings were made just before CPB, at 
5-minute intervals throughout CPB, and after the comple- 
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Fig. 3. A, Representative plot of instantaneous left ventricular pressure and myocardial segment length 
dimension for cardiac ycles over a range of end-diastolic volumes. B, Left ventricular regional stroke work 
expressed as a function of end- diastolic length for each cardiac ycle yields linear relationship with a slope 
and x-intercept. C, The area under the segmental preload recruitable work area versus end-diastolic length 
relationship sequal to the preload recruitable work area (equation 3) for two different time periods in the 
same subject. Lw1 and Lw2 are the different x-intercepts and Lwm ~ is the maximal value of the x-intercept 
for the entire experiment. 
tion of CPB. Blood temperature and cardioplegic solution 
temperature were also measured in series with the CPB 
circuit (YSI series 500; Yellow Springs Instrument Com- 
pany, Yellow Springs, Ohio). 
Ultrastructural nd histologic examination. Ultrastruc- 
tural examination was performed on transmural needle 
biopsy specimens taken from the apex of each ventricle 
before CPB and at 30 and 60 minutes after completion of 
CPB. Most specimens were embedded in paraffin, stained 
with hematoxylin and eosin, and examined with a high- 
power light microscope. Representative specimens were 
also prepared for examination by transmission electron 
microscopy by being rapidly immersed in fresh, cold 3% 
glutaraldehyde in Sorensen's phosphate buffer (0.1 mol/L, 
pH 7.3) for 24 hours. The specimens were then fixed in 
1% osmium tetroxide, dehydrated in acetone, and embed- 
ded in Epon fixative. "Green" sections 0.5 to 1 /xm thick 
were cut, stained with a polychrome stain, and examined 
by light microscopy for orientation purposes. Correspond- 
ing thin sections were cut with an LKB Ultratome III knife 
(LKB Instruments, Inc., Rockville, Md.), mounted on 
copper-coated grids, stained with uranyl acetate and lead 
acetate, and then examined with a Siemens transmission 
electron microscope (Siemens Medical Corp., Iselin, 
N.Y.). Specimens were qualitatively evaluated for myo- 
cyte necrosis, intercellular or intracellular edema, mito- 
chondrial and myofilament abnormalities, cell membrane 
disruption, and microvascular damage. 
Statistical methods. Data were analyzed by the SPSS 
for Windows statistical software program (SPSS, Inc., 
Chicago, Ill.). All results are expressed as the mean - 
standard eviation. The statistical significance of changes 
in load-independent i dexes of ventricular function were 
compared by repeated- measures analysis of variance. 
Significance was determined at the level of 5% or less. 
Results 
Regional myocardial contractile function. When 
the instantaneous left ventricular intracavitary pres- 
sure was plotted against he regional eft ventrieular 
segment length, pressure- length work loops re- 
sulted (Fig. 3). At baseline before the institution of 
CPB, regional myocardial function did not differ in 
the minimally invasive versus conventional groups. 
There were no significant differences in the slopes 
(143.2 _ 12.9 vs 131.3 _+ 21.9 erg × cm -1 X 103) or 
the x-intercepts (4.8 _+ 1.0 vs 4.3 _ 0.7 cm) (p = NS) 
(Table I). The mean linear correlation coefficient 
for the end-diastolic pressure-segment length rela- 
tionship before and after CPB was 96%. There were 
no significant changes with respect to between- 
subject effects in the x-intercept at both 30 and 60 
minutes after the completion of CPB (Fig. 4). There 
were also no significant changes in the slope after 
the completion of CPB (Fig. 5). The mean percent- 
age standard deviations were 3% and 5% for the 
variables lope and x-intercept, respectively. Power 
analysis of our experimental protocol revealed that 
with a power of 80% and a two-tailed t test at the 
level of 5%, we were able to detect a difference 
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Table I. Effects of minimally invasive and conventional CPB and cardioplegic arrest on myocardial 
contractile function 
30 rain 60 rain 
Before CPB after CPB after CPB Significance* 
Mw (erg -  cm-3  1 . 103) 
Min imal ly  invasive 143.2 _+ 12.9 127.5 _+ 17.8 122.3 + 17.6 p = NS 
Convent iona l  131.3 _+ 21.9 122.5 _+ 23.0 119.1 ± 22.0 
Lw (cm) 
Minimally invasive 4.8 +_ 1.0 5.2 + 1.0 5.4 +_ 1.1 p - NS 
Conventional 4.3 +_ 0.7 5.0 _+ 0.6 5.0 _+ 0.6 
Emax (mm Hg/cm) 
Minimally invasive 3[25.4 _+ 58.7 143.0 _+ 69.7 132.0 _+ 84.9 p = NS 
Conventional 107.3 _+ 50.9 103.8 + 59.8 101.4 +_ 60.2 
PRWA (%) 
Minimally invasive 100 69 ± 16 60 _+ 11 p NS 
Conventional 100 65 _+ 18 62 ± 18 
SWEDL (%) 
Minimally invasive 100 89 + 11 85 _+ 10 p NS 
Conventional 100 93 -- 05 91 _+ 04 
Values are mean -+ standard eviation. Slope (Mw), x-intercept (L,O, preload recruitable work area (PRWA), stroke work-end-diastolic ength relationship 
(SWEDL), and maximal regional elastance (Emax). Preload recruitable work area and stroke work-end-diastolic ength relationship are expressed as a 
precent of the prebypass values. 
*Differences between groups tested by two-way analysis of variance for repeated measures. 
between treatment groups if the percentage differ- 
ence between the groups was more than 5% for x- 
intercept and more than 8% for slope. 14 
No significant differences between groups were ob- 
served in the preload recruitable work area (Table I, 
Fig. 6) or stroke work-end-diastolic length relation- 
ships (Fig. 7) at 30 and 60 minutes. The mean linear 
correlation coefficient for the end-systolic pressure- 
segment length relationship before and after CPB was 
95% in both groups. Emax remained relatively con- 
stant throughout the experiment (Table I, Fig. 8). The 
mean changes in Emax after CPB at 30 and 60 minutes 
were not statistically significant. 
Ventricular venting and delivery of cardioplegic 
solution. All subjects' hearts arrested within 90 
seconds after the institution of cardioplegia. Ven- 
tricular venting was obtained in all experiments and 
verified by monitoring of left and right ventricular 
pressUre throughout CPB. The pressures remained 
at 0 to 10 mm Hg after pulmonary artery and aortic 
root venting were instituted and remained at that 
level throughout the CPB period. 
Myocardial temperature. The right and left ven- 
tricuiar temperatures before, during, and after CPB 
are depicted in Fig. 9. The mean myocardial pre- 
CPB temperatures for the minimally invasive and 
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conventional groups were 36.0 ° _+ 0.8 ° and 36.5 ° _+ 
0.5 ° C, respectively. During CPB the heart was 
cooled in the minimally invasive and conventional 
groups to a mean temperature of 17.5 ° +_ 1.4 ° C and 
17.3 ° _+ 1.0 ° C, respectively. With regard to isolated 
cooling of the left ventricle in the minimally invasive 
and conventional groups during CPB, the average 
temperatures were 17.2 ° _+ 1.2 ° and 17.5 ° _+ 1.5 ° C, 
respectively. The right ventricle was cooled to mean 
temperatures of 17.3 ° _+ 1.0 ° C and 17.5 ° _+ 1.4 ° C, 
respectively, in the two groups. At the conclusion of 
aortic crossclamping, the myocardium was re- 
warmed in the minimally invasive and conventional 
groups to 31.9 ° _+ 5.5 ° C and 33.1 ° _+ 1.3 ° C, 
respectively (p = not significant). The blood tem- 
peratures were all above 35 ° C in both groups. 
Ultrastructural examination. No changes were 
noted in either group on gross inspection of the 
postmortem heart specimens. Light microscopic ex- 
amination failed to reveal any widespread egener- 
ative changes in the biopsy specimens. Likewise, 
ultrastructural examination showed no differences 
between prebypass and postbypass pecimens in 
either group with regard to intracellular or intercel- 
lular edema, myofilament and mitochondrial abnor- 
malities, membrane rupture, or microvascular dis- 
ruption or blockage (Fig. i0). 
Discuss ion  
A key point in assessing the efficacy of any new 
CPB-myocardial protection technique is to deter- 
mine the technique's potential for minimizing myo- 
cardial damage during aortic crossclamping and for 
promoting the recovery of myocardial performance 
after reperfusion. In this experiment, all measure- 
ments of regional myocardial performance, includ- 
ing the slope and x-intercept of the stroke work 
versus end-diastolic relationship, the preload re- 
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cruitable work area, the stroke work-end-diastolic 
length relationship, and the Emax were equivalent 
in the minimally invasive group and the conven- 
tional open myocardial protection group. In addi- 
tion, the mean percentage standard deviation for 
each parameter was low with the exception of Emax. 
Despite the small number of subjects in each group, 
we were able to compare the treatment groups with 
respect o the end-diastolic relationships to deter- 
mine if a difference had occurred. 14 This was possi- 
ble because of the low percentage standard evia- 
tions observed in each group. However, the 
variability in Emax could have resulted either from 
magnification of measurement error or, more likely, 
from the true minute-to-minute variation in cardiac 
performance. 
With the exception of Emax, all of the contractile 
performance indexes measured are relatively inde- 
pendent of preload and afterload and are extremely 
sensitive to ischemia. 12 Glower and coworkers 1° 
previously described the variable sensitivity of Emax 
to ischemia and have attributed it to a reversible 
phenomenon called diastolic creep. Some of the 
variability noted in Emax in these experiments may 
be a creep effect. 
A potential limitation of the methods used in the 
experiment is that measuring dynamic ventricular di- 
mensions rather than volume assumes that regional 
ventricular hydrodynamic performance accurately re- 
flects global performance. This assumption appears 
valid because of the consistent correlation between 
segment length and stroke volume and between re- 
gional and global stroke work reported by others. 13 
An important goal of this study was to determine 
if percutaneous endovascular delivery of cardiople- 
gic solution could cool the myocardium as well as 
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Fig. 9. Myocardial regional temperatures of the left and right ventricles before, during, and after CPB. NS, 
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standard open antegrade delivery of cardioplegic 
solution. The results howed equivalent mean tem- 
peratures (approximately 17° C) in each group dur- 
ing CPB. This level of hypothermia was achieved 
despite the absence of topical cooling in these 
experiments. In addition, the ability to bathe the 
heart in cool saline solution should be technically 
feasible in the minimally invasive group. Effective 
decompression of the heart by the endovascular 
aortic catheter technique and endovascular pulmo- 
nary artery vent proved to be clearly possible. This 
ability to unload 15 and decompress the heart is 
thought o be essential for adequate myocardial 
protection. 
The technique of minimally invasive CPB used in 
this study is based on an innovative percutaneous 
vascular access device (the Endoclamp device) that 
provides for endovascular ortic occlusion, delivery 
of cardioplegic solution, and left ventricular decom- 
pression. The Endoclamp device is a triple-lumen 
catheter with an inflatable balloon at its distal end. 
Proper positioning of the balloon is paramount 
because improper placement can result in aortic 
valve incompetence and left ventricular distention, 
unequal distribution of cardioplegic solution, occlu- 
sion of the major head vessels, or an inability to 
adequately arrest the heart. In this study proper 
positioning of the balloon proved to be easily 
achievable by means of fluoroscopic guidance, and 
positioning in human beings should be easier be- 
cause the ascending aorta is longer in the human 
being than in the dog, as has been confirmed 
independently in human cadaver studies. Cardiople- 
gic solution is delivered in an antegrade fashion 
through acentral lumen that communicates with the 
tip. This lumen also acts to vent the aortic root after 
delivery of the cardioplegic solution. A second lu- 
men is used to monitor aortic root pressure. The 
third lumen is used for inflation of the balloon. The 
pulmonary artery venting catheter ispercutaneously 
placed through the external jugular vein and passed 
into the pulmonary artery, so that he heart is vented 
to achieve ventricular decompression. 
Use of this system in combination with percuta- 
neous CPB perfusion allowed the hearts in these 
experiments to be easily arrested, cooled, and 
vented. The overall results demonstrate hat the 
Endoclamp device in association with the endovas- 
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Fig. 10. Electron micrographs of left ventricular biopsy specimens from the sa e animal showing normal 
ultrastructure before minimally inv sive CPB (A) and after 60 minutes of reperfusion (B). (Uranyl acetate 
and lead citrate, ?<6600.) 
cular pulmonary artery venting catheter was able to 
provide complete aortic occlusion, adequate car- 
dioplegic delivery with prompt heart arrest, ade- 
quate myocardial cooling, and excellent myocardial 
functional recovery to an extent equivalent to that of 
conventional techniques. 
The findings of this study demonstrate that mini- 
mally invasive CPB and endovascular cardioplegic 
arrest are technically feasible and effective. The 
technique provides myocardial protection equiva- 
lent to that obtained with open methods. The impli- 
cations of these findings are significant, because 
effective closed chest techniques for myocardial 
protection are necessary if minimally invasive car- 
diac surgery is to become a clinical reality. The 
minimally invasive endovascular myocardial protec- 
tion system studied here provides the foundation for 
development of routine methods for accomplishing 
many types of cardiac operations without median 
sternotomy or thoracotomy. 
We would like to thank Manasse D cady, Francisco 
Rivera, and Eleones Anglade for their exp rt echnical 
assistance. 
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